Objective
The oncogenic fusion protein BCR/ABL causes human leukemia. A specific inhibitor of BCR/ABL is an effective treatment of tumors in vivo. The project aims at investigating molecular mechanisms underlying resistance to the inhibitor in vivo.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesclinical medicineoncologyleukemia
You need to log in or register to use this function
Call for proposal
Data not availableFunding Scheme
RGI - Research grants (individual fellowships)Coordinator
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI
EU contribution
No data
Address
Via Venezian 1
20133 MILANO
Italy
20133 MILANO
Italy
Total cost
No data